Evidence map›Paper›PMID 17664418›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Digital PCR for the molecular detection of fetal chromosomal aneuploidy.

Y M Dennis Lo, Fiona M F Lun, K C Allen Chan, Nancy B Y Tsui, Ka C Chong, Tze K Lau, Tak Y Leung, Benny C Y Zee, Charles R Cantor, Rossa W K Chiu

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
38.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 430 citations in OpenAlex.

  1. Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy.American journal of obstetrics and gynecology · 2009
    Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.Extracellular vesicles and circulating nucleic acids · 2023
    Review
  14. Article
  15. QnAs with Yuk-Ming Dennis Lo: Winner of the 2022 Lasker∼DeBakey Clinical Medical Research Award.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Liquid biopsy: state of reproductive medicine and beyond.Human reproduction (Oxford, England) · 2021
    Review

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Y M Dennis LoLi Ka Shing Institute of Health Sciences, Department of Chemical Pathology, School of Public Health, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong Special Administrative Region, People's Republic of China. loym@cuhk.edu.hk
Fiona M F Lun
K C Allen Chan
Nancy B Y Tsui
Ka C Chong
Tze K Lau
Tak Y Leung
Benny C Y Zee
Charles R Cantor
Rossa W K Chiu
Chinese University of Hong Kong · CNInstitute of Life Sciences · INBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trisomy 21 is the most common reason that women opt for prenatal diagnosis. Conventional prenatal diagnostic methods involve the sampling of fetal materials by invasive procedures such as amniocentesis. Screening by ultrasonography and biochemical markers have been used to risk-stratify pregnant women before definitive invasive diagnostic procedures. However, these screening methods generally target epiphenomena, such as nuchal translucency, associated with trisomy 21. It would be ideal if noninvasive genetic methods were available for the direct detection of the core pathology of trisomy 21. Here we outline an approach using digital PCR for the noninvasive detection of fetal trisomy 21 by analysis of fetal nucleic acids in maternal plasma. First, we demonstrate the use of digital PCR to determine the allelic imbalance of a SNP on PLAC4 mRNA, a placenta-expressed transcript on chromosome 21, in the maternal plasma of women bearing trisomy 21 fetuses. We named this the digital RNA SNP strategy. Second, we developed a nonpolymorphism-based method for the noninvasive prenatal detection of trisomy 21. We named this the digital relative chromosome dosage (RCD) method. Digital RCD involves the direct assessment of whether the total copy number of chromosome 21 in a sample containing fetal DNA is overrepresented with respect to a reference chromosome. Even without elaborate instrumentation, digital RCD allows the detection of trisomy 21 in samples containing 25% fetal DNA. We applied the sequential probability ratio test to interpret the digital PCR data. Computer simulation and empirical validation confirmed the high accuracy of the disease classification algorithm.

Indexed as

AneuploidyAllelic ImbalanceComputer SimulationDown SyndromeFemaleHumansLoss of HeterozygosityPolymerase Chain ReactionPolymorphism, Single NucleotidePregnancyPrenatal DiagnosisRNARNA

Identifiers

PMID17664418
PMCPMC1934923
OpenAlexW2133344765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.